ArticleClinical kidney journal2025
Diagnostic utility of contrast-enhanced ultrasound parameters in classifying lupus nephritis.
Article in Clinical kidney journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Glomerulonephritis through the lens of ultrasound and radiology.World journal of nephrology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus (SLE), with renal biopsy as the diagnostic gold standard. However, biopsy is invasive. This study aims to evaluate the potential of contrast-enhanced ultrasound (CEUS) quantitative parameters as non-invasive predictors in differentiation proliferative LN from non-proliferative LN. Methods: Fifty-eight biopsy-confirmed LN patients who underwent CEUS within 3 days before biopsy were included retrospectively. Patients were categorized into 38 cases of proliferative LN (Class III, IV, and III/IV + V) and 20 cases of non-proliferative LN (Class II and purely Class V). The clinical and laboratory data, conventional US parameters, and CEUS quantitative parameters derived from time-intensity curves (TICs) were analyzed. Multivariate logistic regression and receiver operating characteristic (ROC) curve analysis were performed to determine significant predictors and evaluate the diagnostic performance. Results: Patients with proliferative LN exhibited significantly higher absolute time to peak (∆TTP), half descending time (DT/2) and TIC area under curve (TIC-AUC) values than non-proliferative LN patients ( Conclusions: CEUS quantitative parameters, particularly TIC-AUC, provide a non-invasive approach for identifying proliferative LN, and complement conventional laboratory markers. These findings demonstrate the potential of CEUS in improving LN diagnosis and facilitating clinical evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.